The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

25 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of Novel Potent Reversible and Irreversible Myeloperoxidase Inhibitors Using Virtual Screening Procedure.EBI
Universit£
Substituted 4,6-diaminoquinolines as inhibitors of C5a receptor binding.EBI
Merck Sharp And Dohme Research Laboratories
From Dynamic Combinatorial Chemistry toEBI
Universit£
Novel bis-arylalkylamines as myeloperoxidase inhibitors: Design, synthesis, and structure-activity relationship study.EBI
Universit£
Discovery of 2-(6-(5-Chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide (PF-06282999): A Highly Selective Mechanism-Based Myeloperoxidase Inhibitor for the Treatment of Cardiovascular Diseases.EBI
Pfizer
Inhibition of myeloperoxidase: evaluation of 2H-indazoles and 1H-indazolones.EBI
University Of California
Biologically active eremophilane-type sesquiterpenes from Camarops sp., an endophytic fungus isolated from Alibertia macrophylla.EBI
Universidade Estadual Paulista
Design, synthesis, and structure-activity relationship studies of novel 3-alkylindole derivatives as selective and highly potent myeloperoxidase inhibitors.EBI
Universit£
Evaluation of new scaffolds of myeloperoxidase inhibitors by rational design combined with high-throughput virtual screening.EBI
Universit£
Conception of myeloperoxidase inhibitors derived from flufenamic acid by computational docking and structure modification.EBI
Universit£
Structure-based design, synthesis, and pharmacological evaluation of 3-(aminoalkyl)-5-fluoroindoles as myeloperoxidase inhibitors.EBI
Universite£? Libre De Bruxelles
Discovery of a novel indole pharmacophore for the irreversible inhibition of myeloperoxidase (MPO).EBI
Novartis Institutes For Biomedical Research
Potent Triazolopyridine Myeloperoxidase Inhibitors.EBI
Bristol-Myers Squibb Research And Development
The development of myeloperoxidase inhibitors.EBI
University Sarajevo School Of Science And Technology
Thioxo-dihydroquinazolin-one Compounds as Novel Inhibitors of Myeloperoxidase.EBI
Emory University
Improvements in the minimum binding sequence of C5a: examination of His-67.EBI
Abbott Laboratories
Novel benzothiophene-, benzofuran-, and naphthalenecarboxamidotetrazoles as potential antiallergy agents.EBI
Warner-Lambert
Design, synthesis and biological evaluation of CB1 cannabinoid receptor ligands derived from the 1,5-diarylpyrazole scaffold.BDB
Nanchang University School Of Pharmaceutical Science
Identification of a small molecule beta-secretase inhibitor that binds without catalytic aspartate engagement.BDB
Merck Research Laboratories